Right now, Regeneron is trading for 17x forward earnings estimates, down from more than 25x in the second half of 2024.

As an original manufacturer, Cloud-Clone redefines lab efficiency with high-sensitivity multiplex kits, offering a ...

R&D orchestration platform achieves 66% GMV growth, surpasses $1B in cumulative transactions, and expands product ...

As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, ...

The International Association of Top Professionals (IAOTP) will honor Dr. Kerriann Greenhalgh at their annual awards ...

The company’s cross-disciplinary team lead by a Triple-Dr, Berenika Maciejewicz, applies bioengineering and AI towards human lifespan and healthspan extension.

We take a look at Oxford’s biotech and life sciences hub to discover what makes this historical city a hotspot for scientific ...

Grail (GRAL) stock is plummeting after the company's three-year cancer screening trial failed to meet its main goal ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Gov. J.B. Pritzker wants to let Illinois companies sell their research and development tax credits to other businesses — a move biotech leaders say would funnel much-needed cash to startups and make ...

A handful of states are considering initiatives to increase funding for scientific research as uncertainty around federal ...

The National Security Commission on Emerging Biotechnology is visiting Pittsburgh to talk about how biotechnology and artificial intelligence will play a role in the city.